Human Group IIA Phospholipase A2—Three Decades on from Its Discovery (original) (raw)

Enzymatic and receptor mediated effects of secretory phospholipase A2 on the pathophysiology of inflammatory diseases

Alfred Nji Fonteh

Arachidonate Remodeling and Inflammation, 2004

View PDFchevron_right

Activation of human inflammatory cells by secreted phospholipases A2

Annunziata Frattini

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006

View PDFchevron_right

Biology of Secretory Phospholipase A2

Boris Boyanovsky

Cardiovascular Drugs and Therapy, 2008

View PDFchevron_right

Control of phospholipase A2 activities for the treatment of inflammatory conditions

David Shoseyov

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2006

View PDFchevron_right

Phospholipase A2: A Potential Therapeutic Target in Inflammation and Cancer (In silico, In vitro, In vivo and Clinical Approach)

Prof. Govinda Rao Duddukuri

Journal of Cancer Science & Therapy, 2015

View PDFchevron_right

Cloning and Recombinant Expression of a Structurally Novel Human Secreted Phospholipase A2

Michel Lazdunski

Journal of Biological Chemistry, 2000

View PDFchevron_right

Cloning and Recombinant Expression of Human Group IIF-Secreted Phospholipase A2

Michel Lazdunski

Biochemical and Biophysical Research Communications, 2000

View PDFchevron_right

A Natural Disruption of the Secretory Group II Phospholipase A(2) Gene in Inbred Mouse Strains

Derrick Rancourt

Journal of Biological Chemistry, 1995

View PDFchevron_right

Bacterial expression and simple purification of human group x secretory phospholipase A2

Jože Pungerčar

Acta chimica Slovenica, 2010

View PDFchevron_right

The Step Further to Understand the Role of Cytosolic Phospholipase A 2 Alpha and Group X Secretory Phospholipase A 2 in Allergic Inflammation: Pilot Study

Piotr Kuna

BioMed Research International, 2014

View PDFchevron_right

Phospholipase A2 isoforms: a perspective

sajal chakraborti

Cellular Signalling, 2003

View PDFchevron_right

Novel Mammalian Group XII Secreted Phospholipase A 2 Lacking Enzymatic Activity † , ‡

Michel Lazdunski

Biochemistry, 2003

View PDFchevron_right

Cloning and Recombinant Expression of a Novel Mouse-secreted Phospholipase A2

Michel Lazdunski

Journal of Biological Chemistry, 1999

View PDFchevron_right

Deficiency of Phospholipase A2 Receptor Exacerbates Ovalbumin-Induced Lung Inflammation

Kazuhiro Watanabe

The Journal of Immunology, 2013

View PDFchevron_right

A novel role for phospholipase A2isoforms in the checkpoint control of acute inflammation

Prescilla Perera

The FASEB Journal, 2004

View PDFchevron_right

Lipoprotein-associated phospholipase A2: A new therapeutic target

Eva Lonn

Canadian Journal of Cardiology, 2010

View PDFchevron_right

Secretory Phospholipase A2-IIA and Cardiovascular Disease

Alain Tedgui

Journal of the American College of Cardiology, 2013

View PDFchevron_right

Biological Mode of Action of Phospholipase A and the Signalling and Pro and Anti Inflammatory Cytokines: A Review

Ivan Kahwa

Journal of Advances in Medicine and Medical Research

View PDFchevron_right

Functional site of endogenous phospholipase A2 inhibitor from python serum

Maung Thwin

European journal of biochemistry / FEBS, 2002

View PDFchevron_right

Secretory Phospholipase A2 Receptor-Mediated Activation of Cytosolic Phospholipase A2 in Murine Bone Marrow-Derived Mast Cells

Alfred Fonteh

The Journal of Immunology, 2000

View PDFchevron_right

Biological effects of group IIA secreted phosholipase A2

María Nieto

FEBS Letters, 2002

View PDFchevron_right

Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity

Anita Lewin

Biochemical and Biophysical Research Communications, 1992

View PDFchevron_right

Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study

Andrew Nicolaides

Journal of the American College of Cardiology, 2013

View PDFchevron_right

Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?

Paul A J Krijnen

Cardiovascular Research, 2003

View PDFchevron_right

Therapy with interleukin-2 induces the systemic release of phospholipase-A2

Joke Baars

Cancer Immunology Immunotherapy, 1995

View PDFchevron_right

A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals

Jay Tischfield

Journal of Biological Chemistry, 1997

View PDFchevron_right

A novel anti-inflammatory role for secretory phospholipase A 2 in immune complex-mediated arthritis

Barbara Balestrieri, Jonathan Arm

EMBO Molecular Medicine, 2010

View PDFchevron_right

Phospholipase A2IV Regulates Phagocytosis Independent of Its Enzymatic Activity

Cristiano iurisci

Journal of Biological Chemistry, 2012

View PDFchevron_right

Secreted phospholipase A2 group IIA is a neurotoxin released by stimulated human glial cells

erika villanueva

Molecular and Cellular Neuroscience, 2012

View PDFchevron_right

Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties

Timothy Cunningham

Journal of Inflammation, 2008

View PDFchevron_right